Price to Earning ratio Analysis of Ligand Pharmaceuticals Incorp. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PE
Period Ending - Dec-23
Very Poor PE
91.63
Period Ending - Dec-22
Very Poor PE
-274.88
Growth
133.34 %
Trailing Twelve Months PE
Period Ending - Dec-23
Good PE
16.06
PE Analysis of Ligand Pharmaceuticals Incorp.
| PE Ratio of LGND rose handsomely by 133.34 % this year. |
| PE Ratio with value of 91.63 was highest in Year Dec-23 in last Five Years. |
| PE Ratio with value of -739.22 was lowest in Year Dec-20 in last Five Years. |
| Latest PE Ratio with value of 91.63 is Greater than Average PE of -175.52 in last five years. |
Other PE Related Info of LGND that may interest you.
Ligand Pharmaceuticals Incorp. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LGND | 85.05 | 83.96 | 1.30 % | Biotechnology |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Earning of Ligand Pharmaceuticals Incorp.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PE | 91.63 | -274.88 | 40.58 | -739.22 | 4.28 | 22.89 | 254.96 |
| Change | 133.34 % | -777.33 % | 105.49 % | -17370.56 % | -81.30 % | -91.02 % | 114.69 % |
FY Chart of Price to Earning of Ligand Pharmaceuticals Incorp.
Note : All Data Generated at the End of Trading Hours (EOD Data)